| 190 |
Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1002: Inhibition, Deiodinase 2
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 189 |
Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1009: Inhibition, Deiodinase 1
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 188 |
Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1152: Inhibition, Iodotyrosine deiodinase (IYD)
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 176 |
Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
424: Inhibition, Na+/I- symporter (NIS)
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 175 |
Thyroperoxidase inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
279: Thyroperoxidase, Inhibition
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 192 |
Pendrin inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1155: Inhibition, Pendrin
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 193 |
Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1156: Inhibition, Dual oxidase
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 194 |
Hepatic nuclear receptor activation leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1157: Activation, Hepatic nuclear receptor(s)
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 366 |
Competitive binding to thyroid hormone carrier protein transthyretin (TTR) leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
957: Binding, Transthyretin in serum
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 367 |
Competitive binding to thyroid hormone carrier protein thyroid binding globulin (TBG) leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1831: Binding, Thyroid binding globulin in serum
|
1101: Altered, Amphibian metamorphosis
|
|
|
| 21 |
Aryl hydrocarbon receptor activation leading to early life stage mortality, via increased COX-2 |
Markus Hecker |
BY-SA |
18: Activation, AhR
|
None
|
WPHA/WNT Endorsed |
1.27 |
| 293 |
Increased DNA damage leading to increased risk of breast cancer |
Jessica Helm |
BY-SA |
1194: Increase, DNA damage
|
3 AOs
|
Under Development |
1.80 |
| 294 |
Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer |
Jessica Helm |
BY-SA |
1632: Increase in reactive oxygen and nitrogen species (RONS)
|
4 AOs
|
Under Development |
1.80 |
| 295 |
Early-life stromal estrogen receptor activation by endocrine disrupting chemicals in the mammary gland leading to enhanced cancer risk |
Andrea Hindman |
BY-SA |
None
|
None
|
Under Development |
1.79 |
| 316 |
Trypsin inhibition leading to pancreatic acinar cell tumors |
Shigeru Hisada |
BY-SA |
1720: Trypsin inhibition
|
1725: Pancreatic acinar cell tumors
|
Under Development |
1.60 |
| 445 |
Estrogen Receptor Alpha Agonism leads to Impaired Reproduction |
John Hoang |
BY-SA |
1065: Activation, estrogen receptor alpha
|
1991: Impaired, Reproduction
|
|
|
| 580 |
Mineralocorticoid Receptor Activation Leading to Increased Body Mass Index |
Théo Jamay |
All rights reserved |
2331: Activation, Mineralocorticoid Receptor
|
2335: Increase, body mass index
|
|
|
| 472 |
DNA adduct formation leading to kidney failure |
Manoe Janssen |
BY-SA |
373: Formation, Pro-mutagenic DNA Adducts
|
759: Increased, Kidney Failure
|
|
|
| 421 |
PPARG activation leading to intrahepatic cholestasis |
Yuan Jin |
BY-SA |
None
|
None
|
|
|
| 11 |
Percellome Toxicogenomics Approach for AOP Building: Case study on Pentachlorophenol |
Jun Kanno |
BY-SA |
245: Activation, PXR/SXR
|
None
|
Under Development |
2.5 |
| 619 |
Androgen receptor antagonism leads to delayed preputial seperation via reduced fibroblast growth factor in genital-tubercle tissues |
Travis Karschnik |
BY-SA |
26: Antagonism, Androgen receptor
|
2401: Male preputial separation, failed/delayed
|
|
|
| 521 |
Essential element imbalance leads to reproductive failure via oxidative stress |
Travis Karschnik |
BY-SA |
2205: Increased, essential element imbalance
|
2147: Decreased, Viable Offspring
|
|
|
| 499 |
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release |
Travis Karschnik |
BY-SA |
2146: Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
|
341: Impairment, Learning and memory
|
|
|
| 500 |
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis |
Travis Karschnik |
BY-SA |
2146: Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
|
341: Impairment, Learning and memory
|
|
|
| 167 |
Early-life estrogen receptor agonism leading to endometrial adenosquamous carcinoma via promotion of sine oculis homeobox 1 progenitor cells |
Travis Karschnik |
BY-SA |
111: Agonism, Estrogen receptor
|
1070: Increased, adenosquamous carcinomas of endometrium
|
|
|